Details for 2017800310

Up to date per 04.04.2026

Actions

Title / Product Name

VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017800310

EP Publication Number

3458053

E-Number

1453233

Language

PCT Number

US17033688

Publication Date

27.03.2019 A

08.12.2021 B1

Registration Date

08.12.2021

AT Publication Date

15.12.2021

Application Date

19.05.2017

Registration Number

Priorities

20.05.2016

201662339433 P

IPC

A61K 31/428 20060101AFI20191016BHEP

Maximum Duration of Protection

19.05.2037

Owner

Biohaven Therapeutics Ltd.215 Church Street, Suite 301 New Haven, CT 06510US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

CORIC, Vladimir234 Church Street Suite 301 New Haven Connecticut 06520US

Information about Fees